China-developed AIDS vaccine won government approval to be tested by human
bodies Thursday, according to the State Food and Drug Administration (SFDA) of
China.
The compound vaccine consists of DNA vaccine and regrouped virus carrier,
said sources with the SFDA.
Chinese scientists began the research by studying domestically popular virus
genes in 1996, including the envelope albumen and core albumen of the virus.
They found that human body will become immune to AIDS virus after injecting DNA
vaccine and regrouped virus carrier in succession.
Researchers attacked a monkey with AIDS virus after injecting the compound
vaccine into its body, and found no abnormal reactions occurred.
Human body test, or stage I clinical test, of the compound AIDS vaccine aims
to further assess the security of the vaccine, an SFDA official said.
The government will consider whether to launch stage II and stage III tests
on the basis of the result of the stage I test.
SFDA officials said that they would accelerate approval process of all kinds
of anti-AIDS drugs to help speed up relevant clinicalresearches.
According to experts, AIDS vaccine is the only solution to stop the wildfire
spread of the grievous infectious disease. Currently,even the "cocktail
treatment", the most effective measure to deal with AIDS so far, can only
stabilize or ease the AIDS symptoms instead of killing the virus in the body.
